ARTICLE | Distillery Therapeutics
Therapeutics: ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13)
September 10, 2015 7:00 AM UTC
In vitro studies suggest a modified form of ADAMTS13 could help treat thrombotic thrombocytopenic purpura (TTP). Autoantibodies from TTP patients inhibit ADAMTS13-mediated cleavage of von Willebrand f...